Patient Decision Aids Linked to Improved Perception of Medical Knowledge in Cancer Survivors
the Cancer Therapy Advisor take:
Patients from a patient decision aid (P-DA) trial reported increased knowledge and decision-making confidence compared to those with usual care alone, according to an article published online in the journal Cancer.
Patients with early-stage thyroid cancer at a Canadian tertiary/quaternary care center were contacted 15 to 23 months after randomization and radioactive iodine (RAI) decision-making to examine long-term outcomes.
Of the original 74 patients, 70 (95%) of them enrolled in follow-up at a mean of 17.1 months after randomization.
Results showed patients who used P-DA reported being significantly more informed about the treatment choice, aware of their options, knowledgeable about treatment benefits, and knowledgeable about risks and side effects associated with treatment (P=0.008, P =0.009, P =0.020, and P=0.001, respectively).
No significant differences were observed between the two groups in regards to decision satisfaction (P=0.142), decision regret (P=0 .199), cancer-related worry (P=0 .645), mood (P=0.211), or physician trust (P=0.764).
Patients from a patient decision aid trial reported increased knowledge and decision-making confidence.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Vegan Diet and Cancer
- As HPV-Related Cancer Rates Climb, Experts Scrutinize Barriers to HPV Vaccination
- Bowel Preparation for Colorectal Cancer Screening: Improving Outcomes
- Tool for Assessing Frailty Predicts Survival in Newly Diagnosed Multiple Myeloma
- Analysis Supports Flat Dose of Nivolumab 480 mg Every 4 Weeks
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Prostate Cancer Drug Treatments
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Treatment Delays May Mean Worse Survival in Head and Neck Cancer
- New Combo for Chronic Myeloid Leukemia Shows Activity In Vitro
- Age-adjusted Comorbidity Predicts Survival in Laryngeal Cancer
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Role of miR-125a-5p Clarified in Bladder Cancer